CoChat

Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities

Open access
Zhang, Wenxing, Jin, Chenrui, Liu, Shuyuan, Wan, Xing, Li, Yu, Liu, Jifeng, Duan, Zhijun, Ma, Jingyuan, Gao, Yunhai · 2026 · Frontiers in Immunology

The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.

Abstract

Microsatellite-stable (MSS)/proficient mismatch-repair (pMMR) colorectal cancer (CRC) accounts for more than 85% of cases but responds poorly to single-agent immune checkpoint inhibitors (ICIs), with objective response rates remaining below 5%. A principal barrier to effective immunotherapy in these tumors is a durable immunosuppressive axis formed by myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) within the tumor microenvironment. This axis impedes antitumor immunity through multilayered mechanisms including bidirectional chemotactic recruitment, reciprocal cytokine signaling, metabolic suppression and exosome-mediated communication. CRC is uniquely influenced by the gut microbiota: Fusobacterium nucleatum promotes MDSC/Treg enrichment via TLR4–NF-κB and Fap2–TIGIT pathways; Peptostreptococcus anaerobius acts through integrin–PI3K–NF-κB signaling; and microbial metabolites such as 4-HPA activate JAK2/STAT3–CXCL3 signaling to expand MDSC populations. Concurrently, a hypoxia–lactate–HIF-1α–CD73/A2AR circuit further stabilizes suppressive phenotypes, forming a “microbiota–metabolism–hypoxia–MDSC–Treg” cascade. Emerging clinical and translational data indicate that disrupting this axis can sensitize MSS-CRC to ICIs: for example, Zanzalintinib combined with Atezolizumab reported survival benefit in the STELLAR-303 trial, and dual blockade of novel checkpoints with PD-(L)1 has been associated with enhanced immune activation in solid tumors. Targeting the MDSC–Treg axis therefore represents a promising strategy to overcome immunotherapy resistance in MSS/pMMR CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2026.1757513

Cites

177 of 177 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Chemokine-driven recruitment, mutual induction, and Th17-integrated plasticity of the MDSC–Treg immunosuppressive axis in CRC. Created with BioRender.com.
Figure 1 Chemokine-driven recruitment, mutual induction, and Th17-integrated plasticity of the MDSC–Treg immunosuppressive axis in CRC. Created with BioRender.com.CC BY · PubMed Central
Figure 2 Core molecular mechanisms sustaining the MDSC–Treg immunosuppressive axis in CRC. Created with BioRender.com.
Figure 2 Core molecular mechanisms sustaining the MDSC–Treg immunosuppressive axis in CRC. Created with BioRender.com.CC BY · PubMed Central
Figure 3 Integrated microbiota–metabolism–hypoxia–MDSC–Treg immunosuppressive cascade in microsatellite-stable/proficient mismatch-repair (MSS/pMMR) CRC. Created with BioRender.com.
Figure 3 Integrated microbiota–metabolism–hypoxia–MDSC–Treg immunosuppressive cascade in microsatellite-stable/proficient mismatch-repair (MSS/pMMR) CRC. Created with BioRender.com.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 177 references

Cited by

See all 28

Metadata

Authors
Zhang, W., Jin, C., Liu, S., Wan, X., Li, Y., Liu, J., Duan, Z., Ma, J., & Gao, Y.
Affiliations
  • Liaoning University of Traditional Chinese Medicine (CN)
  • Dalian Medical University (CN)
  • Affiliated Hospital of Liaoning University of Traditional Chinese Medicine (CN)
  • Department of General Surgery, The First Affiliated Hospital of Dalian Medical University
  • First Affiliated Hospital of Dalian Medical University (CN)
Corresponding author
  • Duan, Zhijun
  • Ma, Jingyuan
  • Gao, Yunhai
Venue
Frontiers in Immunology
Published
2026-01-29
Volume
17
Pages
1757513-1757513
ISSN
1664-3224 (ISSN-L)
OpenAlex
W7125904396
Cited by
22
References
177
Citations by year
2026: 22
FWCI
20.05
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
myeloid-derived suppressor cells, regulatory T cells, colorectal cancer, microsatellite stable colorectal cancer, immune checkpoint inhibitors, tumor immunosuppression, gut microbiota, Fusobacterium nucleatum, Peptostreptococcus anaerobius, TLR4/NF-κB signaling, microbial metabolites, 4-hydroxyphenylacetic acid, tumor hypoxia, HIF-1α, immunotherapy resistance, atezolizumab, PD-1/PD-L1 blockade, tumor microenvironment
MeSH terms
Gastrointestinal Microbiome, Myeloid-Derived Suppressor Cells, Animals, Humans, Colorectal Neoplasms, Signal Transduction, T-Lymphocytes, Regulatory, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities. https://app.cochat.ai/papers/10.3389/fimmu.2026.1757513
The paper
Zhang, W., Jin, C., Liu, S., Wan, X., Li, Y., Liu, J., Duan, Z., Ma, J., & Gao, Y. (2026). Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1757513

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.